Pulmatrix, Inc. (PULM)
Total Valuation
Pulmatrix has a market cap or net worth of $6.39 million. The enterprise value is -$4.03 million.
Market Cap | 6.39M |
Enterprise Value | -4.03M |
Important Dates
The last earnings date was Thursday, March 28, 2024, before market open.
Earnings Date | Mar 28, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Pulmatrix has 3.65 million shares outstanding. The number of shares has increased by 5.92% in one year.
Shares Outstanding | 3.65M |
Shares Change (YoY) | +5.92% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 8.59% |
Float | 3.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.88 |
Forward PS | 3.54 |
PB Ratio | 0.36 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.33, with a Debt / Equity ratio of 0.49.
Current Ratio | 5.33 |
Quick Ratio | 5.14 |
Debt / Equity | 0.49 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.90% and return on invested capital (ROIC) is -55.10%.
Return on Equity (ROE) | -63.90% |
Return on Assets (ROA) | -40.90% |
Return on Capital (ROIC) | -55.10% |
Revenue Per Employee | $260,643 |
Profits Per Employee | -$504,321 |
Employee Count | 28 |
Asset Turnover | 0.21 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.22% in the last 52 weeks. The beta is 0.94, so Pulmatrix's price volatility has been similar to the market average.
Beta (1Y) | 0.94 |
52-Week Price Change | -44.22% |
50-Day Moving Average | 1.80 |
200-Day Moving Average | 2.12 |
Relative Strength Index (RSI) | 49.46 |
Average Volume (30 Days) | 16,975 |
Short Selling Information
The latest short interest is 364, so 0.01% of the outstanding shares have been sold short.
Short Interest | 364 |
Short Previous Month | 15,319 |
Short % of Shares Out | 0.01% |
Short % of Float | 0.01% |
Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, Pulmatrix had revenue of $7.30 million and -$14.12 million in losses. Loss per share was -$3.87.
Revenue | 7.30M |
Gross Profit | 7.30M |
Operating Income | -14.74M |
Pretax Income | -14.12M |
Net Income | -14.12M |
EBITDA | -12.65M |
EBIT | -14.12M |
Loss Per Share | -$3.87 |
Balance Sheet
The company has $19.17 million in cash and $8.76 million in debt, giving a net cash position of $10.42 million or $2.85 per share.
Cash & Cash Equivalents | 19.17M |
Total Debt | 8.76M |
Net Cash | 10.42M |
Net Cash Per Share | $2.85 |
Equity / Book Value | 18.00M |
Book Value Per Share | 4.93 |
Working Capital | 16.93M |
Cash Flow
In the last 12 months, operating cash flow was -$15.99 million and capital expenditures -$676,000, giving a free cash flow of -$16.66 million.
Operating Cash Flow | -15.99M |
Capital Expenditures | -676,000 |
Free Cash Flow | -16.66M |
FCF Per Share | -$4.56 |
Margins
Gross margin is 100.00%, with operating and profit margins of -201.97% and -193.49%.
Gross Margin | 100.00% |
Operating Margin | -201.97% |
Pretax Margin | -193.49% |
Profit Margin | -193.49% |
EBITDA Margin | -173.28% |
EBIT Margin | -193.49% |
FCF Margin | -228.30% |
Dividends & Yields
Pulmatrix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.92% |
Shareholder Yield | -5.92% |
Earnings Yield | -220.93% |
FCF Yield | -260.67% |
Analyst Forecast
The average price target for Pulmatrix is $10.00, which is 471.43% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $10.00 |
Price Target Difference | 471.43% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 36.24% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 1, 2022. It was a reverse split with a ratio of 1:20.
Last Split Date | Mar 1, 2022 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
Pulmatrix has an Altman Z-Score of -12.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -12.18 |
Piotroski F-Score | 1 |